Literature DB >> 22178785

Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS).

Michelle R Jones1, Angela K Chua, Emebet A Mengesha, Kent D Taylor, Yii-Der I Chen, Xiaohui Li, Ronald M Krauss, Jerome I Rotter, Richard S Legro, Ricardo Azziz, Mark O Goodarzi.   

Abstract

The role of metabolic disturbance in polycystic ovary syndrome (PCOS) has been well established, with insulin resistance and the resulting compensatory hyperinsulinemia thought to promote hyperandrogenemia. Genome-wide association studies (GWAS) have established a large number of loci for metabolic conditions such as type 2 diabetes and obesity. A subset of these loci has been investigated for a role in PCOS; these studies generally have not revealed a confirmed role for these loci in PCOS risk. However, a large scale investigation of genes related to these pathways has not previously been performed. We conducted a two stage case control association study of 121,715 single nucleotide polymorphisms (SNPs) selected to represent susceptibility loci associated with traits such as type 2 diabetes, obesity measures, lipid levels and cardiovascular function using the Cardio-Metabochip in 847 PCOS cases and 845 controls. Several hypothesis-generating associations with PCOS were observed (top SNP rs2129107, P=3.8×10(-6)). We did not find any loci definitively associated with PCOS after strict correction for multiple testing, suggesting that cardio-metabolic loci are not major risk factors underlying the susceptibility to PCOS. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22178785      PMCID: PMC3689580          DOI: 10.1016/j.steroids.2011.12.005

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  43 in total

Review 1.  Whole-genome genotyping.

Authors:  Kevin L Gunderson; Frank J Steemers; Hongi Ren; Pauline Ng; Lixin Zhou; Chan Tsan; Weihua Chang; Dave Bullis; Joe Musmacker; Christine King; Lori L Lebruska; David Barker; Arnold Oliphant; Kenneth M Kuhn; Richard Shen
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

2.  PLINK: a tool set for whole-genome association and population-based linkage analyses.

Authors:  Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

3.  The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects.

Authors:  Richard S Legro; Evan R Myers; Huiman X Barnhart; Sandra A Carson; Michael P Diamond; Bruce R Carr; William D Schlaff; Christos Coutifaris; Peter G McGovern; Nicholas A Cataldo; Michael P Steinkampf; John E Nestler; Gabriella Gosman; Linda C Guidice; Phyllis C Leppert
Journal:  Fertil Steril       Date:  2006-09-11       Impact factor: 7.329

4.  Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study.

Authors:  Joel A Simon; Feng Lin; Stephen B Hulley; Patricia J Blanche; David Waters; Stephen Shiboski; Jerome I Rotter; Deborah A Nickerson; Huiying Yang; Mohammed Saad; Ronald M Krauss
Journal:  Am J Cardiol       Date:  2006-01-27       Impact factor: 2.778

5.  Polymorphisms of TCF7L2 and HHEX genes in Chinese women with polycystic ovary syndrome.

Authors:  Pei Xu; Yena Che; Yunxia Cao; XiaoKe Wu; Haixiang Sun; Fengjing Liang; Jing Sun; Lu Ke; Long Yi; Yong Wang
Journal:  J Assist Reprod Genet       Date:  2009-12-30       Impact factor: 3.412

6.  Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation.

Authors:  Leslee J Shaw; C Noel Bairey Merz; Ricardo Azziz; Frank Z Stanczyk; George Sopko; Glenn D Braunstein; Sheryl F Kelsey; Kevin E Kip; Rhonda M Cooper-Dehoff; B Delia Johnson; Viola Vaccarino; Steven E Reis; Vera Bittner; T Keta Hodgson; William Rogers; Carl J Pepine
Journal:  J Clin Endocrinol Metab       Date:  2008-01-08       Impact factor: 5.958

7.  Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels.

Authors:  Thomas M Barber; Amanda J Bennett; Anna L Gloyn; Christopher J Groves; Ulla Sovio; Aimo Ruokonen; Hannu Martikainen; Anneli Pouta; Saara Taponen; Michael N Weedon; Anna-Liisa Hartikainen; John A H Wass; Marjo-Riitta Järvelin; Eleftheria Zeggini; Stephen Franks; Mark I McCarthy
Journal:  Eur J Hum Genet       Date:  2007-03-07       Impact factor: 4.246

8.  Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.

Authors:  Eleftheria Zeggini; Michael N Weedon; Cecilia M Lindgren; Timothy M Frayling; Katherine S Elliott; Hana Lango; Nicholas J Timpson; John R B Perry; Nigel W Rayner; Rachel M Freathy; Jeffrey C Barrett; Beverley Shields; Andrew P Morris; Sian Ellard; Christopher J Groves; Lorna W Harries; Jonathan L Marchini; Katharine R Owen; Beatrice Knight; Lon R Cardon; Mark Walker; Graham A Hitman; Andrew D Morris; Alex S F Doney; Mark I McCarthy; Andrew T Hattersley
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

9.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.

Authors: 
Journal:  Nature       Date:  2007-06-07       Impact factor: 49.962

10.  Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS.

Authors:  T M Barber; A J Bennett; C J Groves; U Sovio; A Ruokonen; H Martikainen; A Pouta; A-L Hartikainen; P Elliott; J A H Wass; M-R Järvelin; E Zeggini; S Franks; M I McCarthy
Journal:  Diabetologia       Date:  2007-09-06       Impact factor: 10.122

View more
  11 in total

1.  Leutinizing hormone/choriogonadotropin receptor and follicle stimulating hormone receptor gene variants in polycystic ovary syndrome.

Authors:  Wassim Y Almawi; Bayan Hubail; Dana Z Arekat; Suhaila M Al-Farsi; Shadha K Al-Kindi; Mona R Arekat; Naeema Mahmood; Samira Madan
Journal:  J Assist Reprod Genet       Date:  2015-02-04       Impact factor: 3.412

Review 2.  Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy.

Authors:  David H Abbott; Daniel A Dumesic; Jon E Levine
Journal:  Expert Rev Endocrinol Metab       Date:  2019-02-15

Review 3.  Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome.

Authors:  Elisabet Stener-Victorin; Vasantha Padmanabhan; Kirsty A Walters; Rebecca E Campbell; Anna Benrick; Paolo Giacobini; Daniel A Dumesic; David H Abbott
Journal:  Endocr Rev       Date:  2020-07-01       Impact factor: 19.871

Review 4.  Association between rs7903146 and rs12255372 polymorphisms of transcription factor 7-like 2 gene and polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Ramon Bossardi Ramos; Vitor Costa Fabris; Letícia de Almeida Brondani; Poli Mara Spritzer
Journal:  Endocrine       Date:  2015-02-13       Impact factor: 3.633

5.  Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals.

Authors:  Meredith A Brower; Michelle R Jones; Jerome I Rotter; Ronald M Krauss; Richard S Legro; Ricardo Azziz; Mark O Goodarzi
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

6.  Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome.

Authors:  M A Brower; Y Hai; M R Jones; X Guo; Y-D I Chen; J I Rotter; R M Krauss; R S Legro; R Azziz; M O Goodarzi
Journal:  Hum Reprod       Date:  2019-01-01       Impact factor: 6.918

7.  FADS1-FADS2 gene cluster confers risk to polycystic ovary syndrome.

Authors:  Ye Tian; Wei Zhang; Shigang Zhao; Yinhua Sun; Yuehong Bian; Tailai Chen; Yanzhi Du; Jiangtao Zhang; Zhao Wang; Tao Huang; Yingqian Peng; Ping Yang; Han Zhao; Zi-Jiang Chen
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

Review 8.  Cardiometabolic risk in polycystic ovary syndrome.

Authors:  Katica Bajuk Studen; Marija Pfeifer
Journal:  Endocr Connect       Date:  2018-05-29       Impact factor: 3.335

9.  Genetic alterations within the DENND1A gene in patients with polycystic ovary syndrome (PCOS).

Authors:  Mette B Eriksen; Michael F B Nielsen; Klaus Brusgaard; Qihua Tan; Marianne S Andersen; Dorte Glintborg; Michael Gaster
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

10.  Association between PCOS and autoimmune thyroid disease: a systematic review and meta-analysis.

Authors:  Mirian Romitti; Vitor C Fabris; Patricia K Ziegelmann; Ana Luiza Maia; Poli Mara Spritzer
Journal:  Endocr Connect       Date:  2018-10-26       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.